Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
27.31
-0.87 (-3.09%)
At close: Mar 5, 2026, 4:00 PM EST
27.37
+0.06 (0.22%)
Pre-market: Mar 6, 2026, 6:00 AM EST
Travere Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Travere Therapeutics stock have an average target of 36.25, with a low estimate of 25 and a high estimate of 47. The average target predicts an increase of 32.74% from the current stock price of 27.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Travere Therapeutics stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 7 | 6 | 6 | 6 | 6 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 15 | 15 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $35 → $38 | Hold | Maintains | $35 → $38 | +39.14% | Feb 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +72.10% | Nov 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $26 → $35 | Hold | Maintains | $26 → $35 | +28.16% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $30 → $40 | Strong Buy | Maintains | $30 → $40 | +46.47% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +72.10% | Sep 19, 2025 |
Financial Forecast
Revenue This Year
709.71M
from 490.73M
Increased by 44.62%
Revenue Next Year
937.49M
from 709.71M
Increased by 32.09%
EPS This Year
0.29
from -0.29
EPS Next Year
2.06
from 0.29
Increased by 617.68%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 948.5M | 1.2B | |||
| Avg | 709.7M | 937.5M | |||
| Low | 575.3M | 660.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 93.3% | 73.3% | |||
| Avg | 44.6% | 32.1% | |||
| Low | 17.2% | -7.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.48 | 6.26 | |||
| Avg | 0.29 | 2.06 | |||
| Low | -0.64 | 0.47 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 2,083.4% | |||
| Avg | - | 617.7% | |||
| Low | - | 64.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.